DR-01
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for DR-01, covering 2025-09-29 to 2026-04-17. Get the full timeline:
Most recent: Clinical Trial Update: A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas [Phase 1, Phase 2]